seed
Stage
1
Investors
About
Nuclivision develops Nuclarity, a CE‑marked AI-driven PET image enhancement software that denoises low-count PET scans to enable up to 50% reduction in scan time or radiotracer dose while preserving lesion detectability. The solution integrates with existing scanners, PACS/viewers and is GDPR- and ISO27001-compliant for deployment in clinical nuclear medicine workflows.
Explore Nuclivision's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.